One-year recombinant growth hormone therapy does not improve hemoglobin state and morphology of erythrocytes in growth hormone deficient children. Issue 1 (March 2018)

• Record Type: Journal Article
• Authors: Pankratova, Maria; Yusipovich, Alexander; Vorontsova, Maria; Parshina, Evgenia; Bochkareva, Svetlana; Cherkashin, Alexander; Baizhumanov, Adil; Silicheva, Margarita; Shiryaeva, Tatyana; Maksimov, Georgy; Peterkova, Valentina
• Is Part Of: Pathophysiology. Volume 25:Issue 1(2018)
• Page Start: 13
• Page End: 17
• Publication Date: 2018-03
• Subjects: Children with growth hormone deficiency -- Erythrocyte morphology -- Raman spectroscopy -- Recombinant growth hormone -- Oxyhemoglobin; Physiology, Pathological -- Periodicals; 571.9
• DOI: 10.1016/j.pathophys.2017.09.002
• Languages: English
• ISSNs: 0928-4680

Abstract

Abstract: An increase in growth rates of children suffering from growth hormone deficiency (GHD) subjected to recombinant growth hormone treatment (rGHT) was shown to be accompanied by acceleration of metabolic processes that may stimulate oxygen consumption in various organs and tissues. Therefore, oxygen-transporting properties of RBC should undergo considerable changes during the rGHT. The aim of this study was to examine the effects of rGHT on erythrocyte shape and hemoglobin state in GHD children. The level of oxyhemoglobin (Oxy-Hb) in RBC was analyzed by Raman spectroscopy. The RBC count, mean corpuscular hemoglobin (MCH), mean corpuscular volume (MCV) and other parameters were calculated. The blood of eleven treatment-naive prepubertal children with GHD (aged 3–9, median 5.7 years) was examined and compared with control group (aged 5–7; median 6.0 years) at three time points: 0, 3 and 12 months of rGHT. Before rGHT, the MI in GHD children was higher (median 0.48 vs 0.14 p = 0.0018) and the RBC count was lower (median 4.20 vs 4.96 10 12 cells/L p = 0.0022) than in control group. After the treatment, cell count in GHD patients did not differ significantly from the control group, but Oxy-Hb level became higher (median 0.64 vs 0.41 p = 0.0075). During rGHT, MCV decreased (median 80.3 vs 83.2 μm 3 p = 0.0231). Morphological and functional characteristics of erythrocytes in GHD children were shown to differ significantly from the healthy control group. A twelve-month rGHT partially improved some of the studied parameters but Oxy-Hb level and echinocyte count remained high.